MedTrace Logo

Effect of Short Course of Glucocorticoid in Patients With Diabetes Mellitus(DM) Type 2

NCT03661684 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2023-09-26

No results posted yet for this study

Summary

Participants will receive prednisone 40 mg for 3 days. 75 g oral glucose tolerance test (OGTT), insulin and C-peptide will be measured on day 1 (before prednisone) and day 3 (after prednisone). Also capillary glucose values will be obtained during and after the period of prednisone intake.

Conditions

  • Diabetes
  • Hyperglycemia Steroid-induced

Interventions

DRUG

Prednisone

40 mg po q day of Prednisone for 3 days

Sponsors & Collaborators

  • Cook County Health

    lead OTHER_GOV

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-03
Primary Completion
2017-04-01
Completion
2017-07-01
FDA Drug
Yes

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03661684 on ClinicalTrials.gov